Synthesis of Prodrug‐Type Oligonucleotides Modified With a Galactosylated Self‐Immolative Linker Cleavable by β‐Galactosidase

This protocol describes procedures for the preparation of a modified thymidine conjugated with galactose via a self-immolative linker at the O4-position, and the synthesis of β-galactosidase-responsive prodrug-type oligodeoxynucleotides (ONs) containing these modified thymidines. These prodrug-ONs are designed to be activated in response to β-galactosidase, enabling targeted activation in specific cells or tissues and potentially contributing to the reduction of adverse effects. © 2025 Wiley Periodicals LLC. Basic Protocol 1: Preparation of O4-modified thymidine phosphoramidite 7 Basic Protocol 2: Preparation of O4-modified thymidine phosphoramidite 15 Support Protocol 1: Preparation of triazolyl thymidine derivative 1 Support Protocol 2: Preparation of benzyl alcohol derivative 2 Basic Protocol 3: Preparation of β-galactosidase-responsive ODNs 1 to 5.

Authors

Institutions

Publication Details

Journal
Current Protocols
Published
2025-04-01
DOI
https://doi.org/10.1002/cpz1.70128
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthesis of Prodrug‐Type Oligonucleotides Modified With a Galactosylated Self‐Immolative Linker Cleavable by β‐Galactosidase

Kohji Seio, Y. MASAKI, Kento Miyaji
Current Protocols
RNA Interference and Gene Delivery
article

Synthesis of Prodrug‐Type Oligonucleotides Modified With a Galactosylated Self‐Immolative Linker Cleavable by β‐Galactosidase

Kohji Seio, Y. MASAKI, Kento Miyaji
article en

Abstract

This protocol describes procedures for the preparation of a modified thymidine conjugated with galactose via a self-immolative linker at the O4-position, and the synthesis of β-galactosidase-responsive prodrug-type oligodeoxynucleotides (ONs) containing these modified thymidines. These prodrug-ONs are designed to be activated in response to β-galactosidase, enabling targeted activation in specific cells or tissues and potentially contributing to the reduction of adverse effects. © 2025 Wiley Periodicals LLC. Basic Protocol 1: Preparation of O4-modified thymidine phosphoramidite 7 Basic Protocol 2: Preparation of O4-modified thymidine phosphoramidite 15 Support Protocol 1: Preparation of triazolyl thymidine derivative 1 Support Protocol 2: Preparation of benzyl alcohol derivative 2 Basic Protocol 3: Preparation of β-galactosidase-responsive ODNs 1 to 5.

Current ProtocolsVol. 5(4)
Life Science Institute (JP)
Openalex Percentile: Top 94%
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.